PATENT CLAIM ANALYSIS

Application Number: 15770443
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["424", "400000"]

Abstract:
Physically and chemically stable oral liquid formulations of Givinostat (Diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphthalen-2-yl-methyl]-ammonium chloride) are disclosed, together with methods for the preparation thereof. Such oral formulations are in the form of aqueous suspensions and contain Givinostat and/or pharmaceutically acceptable salts and/or derivatives thereof, at least a wetting agent and/or at least a density-imparting agent. Such formulations are suitable for oral administration for systemic therapeutic action.

Claim (Index 21):
The method according to  claim 19 , characterized in that it is administered orally.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 91.0
- Lexical Diversity: 1.48077
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14353141', '14994497', '13979997', '13138047', '15208957']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7116868330737691
- 35 USC 102 Novelty (BERT): 0.5137508407392838
- Combined Prediction Score: 0.6918932338403205
- Mean Citation Score: 156.78560199999995
- Max Citation Score: 163.81133
- Similarity Product: 81.69174736140192

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test